Document Detail

Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma.
MedLine Citation:
PMID:  23142105     Owner:  NLM     Status:  Publisher    
There is growing interest on the correlation among oxidative stress, inflammation, apoptosis and primary open-angle glaucoma initiation and progression. Reactive oxygen species are formed in the eyes following a wide variety of stressors, and are largely implicated in glaucoma pathogenesis. Immune-inflammatory response mediators have recently become a target of ophthalmologic concern, including glaucoma. Much attention has been derived to the role of specific pro and anti-apoptotic molecules in glaucoma. This article reviews the early evidence suggesting that reactive oxygen species, immune inflammatory response mediators, and apoptogenic molecules are engaged in glaucoma disease. Moreover, further research concerning the functions, effectors and signaling pathways of the above molecules and their interactions, may lead to specifically develop targeted screening tools based on presumptive biomarkers and surrogate endpoints against primary open-angle glaucoma progression and blindness.
Maria D Pinazo-Durán; Vicente Zanón-Moreno; Jose J García-Medina; Roberto Gallego-Pinazo
Related Documents :
14524475 - Lytic replication of human herpesvirus 8 and induction of apoptosis.
12440735 - Effects of polyphenolic anthrone derivatives, resistomycin and hypercin, on apoptosis i...
9698035 - Cyclic amp-specific phosphodiesterase inhibitor rolipram and ro-20-1724 promoted apopto...
14746955 - Does granulosa cell apoptosis have a role in the etiology of unexplained infertility?
12482325 - The anti-apoptotic effect of leukotriene d4 involves the prevention of caspase 8 activa...
21792205 - Ganodermycin, a novel inhibitor of cxcl10 expression from ganoderma applanatum.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Current opinion in pharmacology     Volume:  -     ISSN:  1471-4973     ISO Abbreviation:  Curr Opin Pharmacol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100966133     Medline TA:  Curr Opin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Ophthalmic Research Unit "Santiago Grisolia", Valencia, Spain; Department of Surgery/Ophthalmology, Faculty of Medicine, University of Valencia, Spain. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nanomedicine for the treatment of retinal and optic nerve diseases.
Next Document:  Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and...